APA (7th ed.) Citation

Mastrella, G., Herold-Mende, C., & Kleber, S. (2019). Targeting APLN/APLNR improves antiangiogenic efficiency and blunts proinvasive side effects of VEGFA/VEGFR2 blockade in glioblastoma. Cancer research, 79(9), . https://doi.org/10.1158/0008-5472.CAN-18-0881

Chicago Style (17th ed.) Citation

Mastrella, Giorgia, Christel Herold-Mende, and Susanne Kleber. "Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma." Cancer Research 79, no. 9 (2019). https://doi.org/10.1158/0008-5472.CAN-18-0881.

MLA (9th ed.) Citation

Mastrella, Giorgia, et al. "Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma." Cancer Research, vol. 79, no. 9, 2019, https://doi.org/10.1158/0008-5472.CAN-18-0881.